However, the prescribing information for Wegovy (another semaglutide product) does have a warning about avoiding use of the drug in people with a history of suicidal thoughts or behaviors
For most GLP-1 medications, alopecia is not listed as a common adverse effect in the Summary of Product Characteristics (SmPC) approved by the Medicines and Healthcare products Regulatory Agency (MHRA)
If youre flying, its smart to keep your medication with you in your carry-on bag
Morning administration is preferable for patients who want to benefit from appetite suppression at work
The number of TEAEs during exposure to treatment was the primary outcome in the Japanese safety study, PIONEER 10
Therefore, in the NRF2 antioxidant regulatory factors category, both activation-related regulatory factors and downstream antioxidant factors or antioxidant systems are included